SMS Pharmaceuticals share news, announcements and annual reports
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
SMS Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2007
Last close ₹504.15down ₹7.20 (1.41%)BSE ₹504.25
Share price at the NSE close on 2 Nov 2026. Previous close ₹511.35.
2 Nov: open ₹511.00, high ₹514.80, low ₹471.25
52-week range of traded prices to 2 Nov 2026
₹270.10Low, 24 Nov 2025₹525.00High, 30 Oct 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,721 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,24,26833.2% delivered
SMS Pharmaceuticals share news and announcements
718 announcements, routine notices left out, newest first. Page 14 of 15.
Feb 2010
1 Feb · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on January 30, 2010) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
7 Jan · Board meeting
Interalia, to consider the Un-audited Financial Results of the company for the quarter ended December 31, 2009.
Dec 2009
14 Dec · Updates
Sms Pharmaceuticals Limited had informed the Exchange that " Our prestigious State of Art API Facility Unit-VII at Kandivalasa Village-535204, Pusapatirega Mandal, Vizianagaram Dist, A.P. which was set up at a cost of Rs. 113.00 crores will be inaugurated on December 12, 2009 by Sri Konijeti Rosaiah, Hon'ble Chief Minister of Andhra Pradesh". The Company has now informed the Exchange that the inauguration program of our prestigious State of Art API Facility, Unit-VII at Kandivalasa Village, Pusapatirega Mandal, Vizianagaram District of Andhra Pradesh scheduled for December 12, 2009, stands postponed due to political uncertainty in Andhra Pradesh. Further, the company has informed that the operations at the unit have been started. Further the company also informs that "We would take decision on formal inauguration once the political stability returns".9 Dec · Updates
Our prestigious State of Art API Facility Unit-VII at Kandivalasa Village-535204, Pusapatirega Mandal, Vizianagaram Dist, A.P. which was set up at a cost of Rs. 113.00 crores will be inaugurated on December 12, 2009 by Sri Konijeti Rosaiah, Hon'ble Chief Minister of Andhra Pradesh
Oct 2009
28 Oct · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on October 28, 2009) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Oct · Meeting
Minutes of the Annual General Meeting of the Company held on September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Oct · Board meeting
Meeting on 28 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”8 Oct · Outcome of meeting
In our Management Committee of Directors Meeting held on 08.10.2009 the Management Committee has taken the following decision:- 'Considered and appointed Mr. P. Prabhakara Rao as Company Secretary of the Company w.e.f. 01.10.2009'.
Sep 2009
30 Sep · Meeting
Members at the Annual General Meeting of the Company held on September 30, 2009 have accorded the followings:- (1) Adopted the Audited Balance sheet as at March 31, 2009 and statement, of profit & Loss Account for the year ended on that date, together with the Director's Report and Auditors Report thereon. (2) Approved the declaration of Dividend of Rs.2.00 per equity share i.e.@ 20% for the year ended March 31, 2009. (3) Re-appointed Dr. Mihir K Chaudhuri and Dr. B.M. Choudary, Directors who retired by rotation (4) Appointed M/s. Rambabu & Co. Charted Accountants and M/s. P. Murali & Co., Charted Accountants, the retiring Joint Statutory Auditors as Joint Statutory Auditors of the Company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company. Further the members have transacted the following Special Business and passed the resolutions unanimously. (1) To appoint Dr. Ayman Sahli as Director of the Company pursuant to Section 257 read with the Section 260 of the Companies Act, 1956. (2) To enhance the Borrowing Powers from Rs. 125.00 Crores to Rs.300.00 Crores.7 Sep · Change in registered office
In the meeting of Management Committee of Directors of the Company held on September 05, 2009, the Committee has taken a decision to shift the Registered Office of the Company from 417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad-500 038 to Plot No.19-III, Road No.71, Opp. Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad-500 034, with effect from October 01, 2009.
Aug 2009
11 Aug · Updates
The Andhra Pradesh Pollution Control Board (APPCB) has issued temporary revocation of the closure orders vide its Order No. 1191/PCB/TF-HYD/2009-180 dated 01.08.2009 with immediate effect. SMS Unit- IV has commenced operations.10 Aug · Meeting
In the Board Meeting held on August 10, 2009 the Board has taken the following decisions: (1) Annual General Meeting of the Company will be held on September 30, 2009. (2) The register of members and the share transfer books of the company will remain closed from September 25, 2009 to September 30, 2009 (both days inclusive) for the purpose of payment of Dividend and convening of the Annual General Meeting on September 30, 2009.10 Aug · Dividend
In the Board Meeting held on August 10, 2009 the Board has taken the following decisions: Recommended dividend of Rs.2/- per equity share of Rs.10/- each on the paid up share capital of the company for the year 2008-09.
Jul 2009
25 Jul · Updates
In Board Meeting held on July 25, 2009 the Board has taken the following decisions:- (1) Enhancement of the Borrowing powers from Rs.125.00 crores to Rs.300.00 crores subject to the approval of the Shareholders of the Company in the forthcoming Annual General Meeting to be held in the last week of September, 2009.25 Jul · Board meeting
For considering the Audited Annual Accounts for the year ended on March 31, 2009.25 Jul · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on July 25, 2009) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jul · Updates
On the intervening night of July 19, 2009 the officials of Andhra Pradesh Pollution Control Board (APPCB), Hyderabad inspected company's Unit-IV situated at Plot No.66/B/2, Phase-I, IDA, Jeedimetla, Rangareddy, Dist., A.P. The APPCB issued Closure orders vide their letter dated July 20, 2009 alleging "manufacturing new products and exceeding consented capacities", which is under investigation. The Company has further informed the Exchange that the company have all the pollution control systems and hence would tide over this issue. The Company is having four manufacturing facilities in addition to the above unit and all are operating without any impediments.6 Jul · Board meeting
Meeting on 25 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
4 May · Board meeting
In the Board Meeting held on April 30, 2009, the Board has taken the following decisions: 1) Authorised Mr. P. Ramesh Babu, Chairman & Managing Director of the Company for Appointment of Cost Auditor for the year 2008-09. 2) Appointment of Dr. Ayman Shali, Nominee Director of Gulf Pharmaceutical Industries, U.A.E. in place of Mr. Abdul Razzaq Yousef.
Apr 2009
9 Apr · Rating
Our Company has been awarded a CRISIL Rating of "SME 1". This rating indicates Highest Level of creditworthiness, adjusted to relation to other SMEs. This rating is valid up to 18th March, 20101 Apr · Board meeting
Interalia to consider the un-audited financial results of the Company for the quarter ended on March 31, 2009.
Mar 2009
16 Mar · Updates
The Pollution Control Board (PCB) has issued temporary revocation of the closure orders vide its Order No.MDK-74/PCB/TF-BO/2008 dated March 13, 2009 with immediate effect satisfied with the environmental management measures taken in the units. SMS Unit-I has commenced operations.
Feb 2009
2 Feb · Updates
On the intervening night of 30th Jan, a mob has attacked one of our manufacturing facilities located at Kazipalli industrial area (Unit I) alleging pollution problems, which is under investigation. Pollution Control Board meanwhile has issued closure orders to pacify the mob and are further investigating their allegations. We would like to assure that we have all the pollution control systems and hence would tide over this issue. We would submit updates on this from time to time. The Company is having four manufacturing facilities in addition to the above unit and all are operating without any impediments
Jan 2009
28 Jan · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 27, 2009) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jan · Management
Board of Directors at it meeting held on January 27, 2009 has taken the following decisions:- Acceptance of Resignation of Mr. R. Sreenivasa Rao, Company Secretary.19 Jan · Meeting
Minutes of the Annual General Meeting of the Company held on December 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
Meeting on 27 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Dec 2008
29 Dec · Meeting
Members at the Annual General Meeting of the Company held on December 29, 2008, inter alia, have accorded the following : (1)Declaration of Dividend of Rs. 2.00 per equity share or 20% on equity shares of Rs. 10/- each, for the year ended March 31, 2008. (2) Re-appointment of Mr. K.S. Rao and Mr. A.P. Rao as Directors of the Company. (3)Appointment of M/s. Rambabu & Co. ,Chartered Accountants and M/s. P. Murali & Co. Chartered Accountants as Joint Auditors of the Company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company. (4) Re-appointment of Mr. P. Ramesh Babu, Chairman and Managing Director for a further period of 5 (five) years with effect from December 01, 2008 on the terms and conditions as set out in the Resolution. (5) Re-appointment of Mr. TVVSN Murthy, Vice Chairman and Joint Managing Director for a further period of 5 (five) years with effect from December 01, 2008 on the terms and conditions as set out in the Resolution. (6) Appointment of Mr. T.V. Praveen as Vice President (Marketing) of the Company subject to Central Government approval for a period of 5 (Five) years with effect from January 01, 2009 to December 31, 2014 with a remuneration as set out in the Resolution.1 Dec · Allotment of shares
Board of Directors in their meeting held on November 29, 2008 has allotted 12,978 Equity Shares of Rs. 10/- each to the erstwhile shareholders of M/s Plant Organics Limited, to implement the Board for Industrial & Financial Reconstruction (BIFR) order dated August 28, 2008. The allotted shares will rank pari passu in all respects with the existing shares of the Company.1 Dec · Meeting
In the Board Meeting held on November 29, 2008 the Board has taken the following decisions: (1)Considered and approved the Audited Financial Results for the year ended on March 31, 2008. (2)Recommended 20% dividend on the paid up share capital of the Company for the year 2007-08. (3)Annual General Meeting of the Company will be held on December 29, 2008. (4)The register of members and the share transfer books of the Company will remain closed from December 26, 2008 to December 29, 2008 (both days inclusive). (5)Considered Mr. T.V.Praveen as an employee of the Company pursuant to Section 314(1B) of the Companies Act, 1956.
Nov 2008
21 Nov · Board meeting
To consider the followings: (1) To consider and approve the Audited Annual Accounts for the year ended on March 31, 2008. (2) To consider the payment of dividend for the year 2007-08, if any. (3) To fix the date of Annual General Meeting of the Company. (4) To consider any other matter with the permission of the chair.3 Nov · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on October 31, 2008) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Nov · Board meeting
Board of Directors of the Company at its meeting held on October 31, 2008 has taken the following decisions: (1) Re-appointed Mr. P. Ramesh Babu, CMD for a further period of 5 years with effect from December 01, 2008. (2) Re-appointed Mr. TVVSN Murthy, VC & JMD for a further period of 5 years with effect from December 01, 2008.
Oct 2008
20 Oct · Board meeting
Interalia, to consider :- 1) The un-audited financial results of the Company for the quarter ended on September 30, 2008. 2) Re-appointment of Mr. P. Ramesh Babu, Chairman and Managing Director. 3) Re-appointment of Mr. TVVSN Murthy, Vice-chairman and Jt. Managing Director.10 Oct · Business
Press release dated October 10, 2008 titled "World Class Oncology Manufacturing Facility of SMS Pharmaceuticals Inaugurated". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
23 Sep · Business
The Board of Industrial & Financial Reconstruction of India (BIFR) has approved the Modified rehabilitation Scheme vide its order dated 17.09.2008 for the merger of M/s. Plant organics Limited (POL) with M/s SMS Pharmaceuticals Limited with effect from 01.01.2008. The Scheme envisages the company to offset the un-absorbed business losses of the M/s Plant Organics Limited beyond the period of 8 years under the Income-tax Act, 1961 and issuance of shares to the share holders of POL in the exchange ratio of 1: 50 on the Reduced capital of Plant Organics Limited apart from other relief's and concessions
Aug 2008
29 Aug · Meeting
Minutes of the Extra Ordinary General Meeting of the members of the Company held on August 26, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Aug · Meeting
Outcome of Extra Ordinary General Meeting held on August 26, 2008. The members have taken the following decisions:- 1. Considered and approved the Scheme of Amalgamation of M/s. Plant Organics Limited with M/s. SMS Pharmaceuticals Limited pursuant to the provisions of Section 18 of the Sick Industrial Companies (Special Provisions) Act, 1985. 2. Considered and approved the issue of Shares to the Shareholders of M/s. Plat Organics Limited in the proportion of 1:50 i.e. 1 (one) equity share of Rs. 10/- of the company for every 50 equity shares of Rs. 10/- each of M/s. Plant Organics Limited to the persons who are members of M/s. Plant Organics Limited on such date as may hereafter be fixed by the Board of company.27 Aug · Extension
We proposed to present the consolidated financials of our Company to the shareholders, post amalgamation of the Sreenivasa Pharma Private Limited (erstwhile wholly owned subsidiary company) and M/s. Plant Organics Limited, a sick Company under the SICA Act, 1985. By way of abundant caution, we sought the Registrar of Companies, A.P. Hyderabad for extension of time to hold our Annual General Meeting up to 31.12.2008. The Registrar of Companies, A.P., Hyderabad vide its order dated 26.08.2008 has granted approval for extension of time to hold our Annual General Meeting up to 31.12.20088 Aug · Meeting
Notice of the Extra-Ordinary General Meeting to be held on August 26,2008. A copy of the notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
30 Jul · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on July 30, 2008) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the previous year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jul · Meeting
Board Meeting held on July 30, 2008 has taken the following decisions:- (1) Appointed Mr. S. Srinivas, Deputy General Manager of Export-Import Bank of India, as their Nominee Director in place of Mr. Vinod Goel. (2) Approval of the notice of Extra-Ordinary General Meeting of the Company to be held on August 26, 2008 in connection with the Merger of Plant Organics Limited.21 Jul · Board meeting
Meeting on 30 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”15 Jul · Business
The Scheme of Amalgamation of Sreenivasa Pharma Pvt. Limited (a wholly owned company) with our Company has been approved by the Hon'ble High Court of A.P., Hyderabad on 19.06.2008
May 2008
3 May · Utilisation of Funds
Vide notes to Accounts in the unaudited financial results for the quarter ended March 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on April 30, 2008) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
22 Apr · Board meeting
Meeting on 30 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Feb 2008
11 Feb · Updates
SMS pharmaceuticals LTD have inaugurated its world class, state of the art - Global Research & Development Centre in Hyderabad on Sunday 10th February at Hyderabad by Dr. A Chakravarthy, Chairman, National Institute of Pharma education and research (NIPER). The new research facility was constructed in an area admeasuring 7.20 Acers with 99842 Sft Build up area including pilot scale development plant comprising with separate quality assurance block. Speaking on this occasion, Mr. P.Ramesh Babu, CMD, said this will facilitate the company to foray into the Contract Research and Manufacturing services (CRAMS). The integrated R&D facility will provide impetus to the company to scale up new products, NCE's and in synthesizing the alternate routes for existing products4 Feb · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 31, 2008) regarding the details of amount spent out of the funds raised, by IPO and other sources, during the year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
19 Jan · Board meeting
Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”8 Jan · Updates
The prestigious Indo-US GCNC Award conferred on our Company on 07.01.2008 in recognition of our Company's adopting Green Chemistry Mandates in the Industry. Our environmental friendly manufacturing practices while manufacturing the Bulk Drugs and conversion of hazardous waste into biodegradable usage process with commercial value were lauded in the Indo-US S & T forum workshop on Green Chemistry. The prestigious GCNC award was handover to our Chairman and Managing Director Mr. P. Ramesh Babu, in the Indo-US S & T form workshop on Green Chemistry held on 7th January, 2008 at New Delhi